These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 26339947)

  • 21. Long term prognosis of medullary thyroid carcinoma in 39 patients.
    Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
    Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary thyroid carcinoma in Hong Kong Chinese patients.
    Chow SM; Chan JK; Tiu SC; Choi KL; Tang DL; Law SC
    Hong Kong Med J; 2005 Aug; 11(4):251-8. PubMed ID: 16085941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymph node involvement and prognosis in medullary cancers of the thyroid gland].
    Mathonnet M; Cubertafond P; Teissier MP; Boutros-Toni F; Gainant A
    Chirurgie; 1994-1995; 120(12):117-22. PubMed ID: 8746014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micromedullary thyroid cancer: how micro is truly micro?
    Pillarisetty VG; Katz SC; Ghossein RA; Tuttle RM; Shaha AR
    Ann Surg Oncol; 2009 Oct; 16(10):2875-81. PubMed ID: 19568813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Medullary thyroid cancer: surgical results and prognostic factors].
    Dequanter D; Lothaire P
    Rev Med Liege; 2010; 65(7-8):450-2. PubMed ID: 20857703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Surgical treatment and prognosis analysis on medullary thyroid carcinoma].
    Zhang ZX; Li ZJ; Tang PZ; Xu ZG; Zhang ZM; An CM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 46(3):209-13. PubMed ID: 21575412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005.
    Grozinsky-Glasberg S; Benbassat CA; Tsvetov G; Feinmesser R; Peretz H; Shimon I; Lapidot M
    Thyroid; 2007 Jun; 17(6):549-56. PubMed ID: 17614776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD; Chen SL; Schneider PD; Martinez SR
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of reoperations for medullary thyroid carcinoma.
    Fialkowski E; DeBenedetti M; Moley J
    World J Surg; 2008 May; 32(5):754-65. PubMed ID: 18188643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in patients with medullary thyroid cancer after less than the recommended initial operation.
    Randle RW; Bates MF; Schneider DF; Sippel RS; Pitt SC
    J Surg Oncol; 2018 May; 117(6):1211-1216. PubMed ID: 29266278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
    Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
    Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
    Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
    Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
    [No Abstract]   [Full Text] [Related]  

  • 35. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarker-based risk stratification for previously untreated medullary thyroid cancer.
    Machens A; Dralle H
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2655-63. PubMed ID: 20339026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
    Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
    Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
    [No Abstract]   [Full Text] [Related]  

  • 38. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
    Gimm O; Ukkat J; Dralle H
    World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surgical management of upper mediastinal lymph nodes metastases from thyroid carcinoma].
    Li ZJ; Miao XX; Tang PZ; Xu ZG; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):145-7. PubMed ID: 16750024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.